HP
LCI

HealthInvest Partners’s Lannett Company, Inc. LCI Stock Holding History

HealthInvest Partners’s Portfolio LCI Stock Details LCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500,000
Closed -$3.24M – 17
2021
Q4 		$3.24M Buy
500,000
+56,250
+13% +$482K 4.57% 10
2021
Q3 		$5.33M Buy
+443,750
New +$7.18M 7.98% 6

Other funds holding LCI

TC
Telemus Capital Southfield, Michigan $1.21B AUM 23.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

HealthInvest Partners's LCI Position: Q1 2022 in Review

HealthInvest Partners sold out of Lannett Company, Inc. (LCI) in Q1 2022, closing a stake of 500,000 shares — an estimated $3.24M sold.

HealthInvest Partners first reported a position in LCI in Q3 2021 and held it in 2 quarters. The position peaked at $5.33M in Q3 2021. 63 funds tracked by Wall St. Rank hold LCI as of Q1 2022.

  • HealthInvest Partners reported no remaining Lannett Company, Inc. position as of Q1 2022 after selling out during the quarter.
  • HealthInvest Partners sold 500,000 Lannett Company, Inc. shares in Q1 2022, an estimated $3.24M.
  • HealthInvest Partners first reported a position in Lannett Company, Inc. in Q3 2021 and held it in 2 quarters.
  • HealthInvest Partners's Lannett Company, Inc. position peaked at $5.33M in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Lannett Company, Inc. as of Q1 2022.

Based on HealthInvest Partners's 13F filing for Q1 2022, filed 5 May 2022.